BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22584709)

  • 1. Genotype-phenotype correlation in multiple endocrine neoplasia type 2.
    Raue F; Frank-Raue K
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):69-75. PubMed ID: 22584709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET codon 609 mutations: a contribution for better clinical managing.
    Mian C; Sartorato P; Barollo S; Zane M; Opocher G
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):33-6. PubMed ID: 22584703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
    Toledo SP; dos Santos MA; Toledo Rde A; Lourenço DM
    Clinics (Sao Paulo); 2006 Feb; 61(1):59-70. PubMed ID: 16532227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management.
    Raue F; Frank-Raue K
    Hormones (Athens); 2009; 8(1):23-8. PubMed ID: 19269918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.
    Frank-Raue K; Rondot S; Raue F
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):2-7. PubMed ID: 20083156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
    Jung KY; Kim SM; Kim MJ; Cho SW; Kim BW; Lee YS; Jeong JJ; Nam KH; Chung WY; Lee KE; Chung EJ; Kim HJ; Park DJ; Sung MW; Park CS; Cho BY; Park YJ; Chang HS
    Surgery; 2018 Aug; 164(2):312-318. PubMed ID: 29779869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome.
    Lendvai N; Tóth M; Valkusz Z; Bekő G; Szücs N; Csajbók E; Igaz P; Kriszt B; Kovács B; Rácz K; Patócs A
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):85-9. PubMed ID: 22584711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 2: 2007 update.
    Raue F; Frank-Raue K
    Horm Res; 2007; 68 Suppl 5():101-4. PubMed ID: 18174721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2.
    Tavares MR; Toledo SP; Montenegro FL; Moyses RA; Toledo RA; Sekyia T; Cernea CR; Brandão LG
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):149-54. PubMed ID: 22584721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endocrine neoplasia: the Chilean experience.
    Diaz RE; Wohllk N
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):7-11. PubMed ID: 22584699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 2.
    Lodish M
    Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
    Niederle B; Sebag F; Brauckhoff M
    Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hirschsprung's-multiple endocrine neoplasia connection.
    Moore SW; Zaahl M
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):63-7. PubMed ID: 22584708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
    González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
    Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary medullary thyroid carcinoma syndromes: experience from western India.
    Diwaker C; Sarathi V; Jaiswal SK; Shah R; Deshmukh A; Thomas AE; Prakash G; Malhotra G; Patil V; Lila A; Shah N; Bandgar T
    Fam Cancer; 2021 Jul; 20(3):241-251. PubMed ID: 33392850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Krampitz GW; Norton JA
    Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.